The 44th Annual J.P. Morgan Healthcare Conference ran January 12–15, 2026, in San Francisco, drawing biopharma, medtech, investors, and health-tech leaders into a market that many described as shifting from austerity toward more measured expansion. The prevailing message was not growth at any cost, but growth with discipline—shaped by an improving cost-of-capital backdrop after a … JPM 2026 Recap: Capital Markets Reopen, AI Moves to the Last Mile, Metabolic Stakes Climb Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.